Otezla and VOMITING

6,427 reports of this reaction

1.7% of all Otezla reports

#10 most reported adverse reaction

Overview

VOMITING is the #10 most commonly reported adverse reaction for Otezla, manufactured by Amgen, Inc. There are 6,427 FDA adverse event reports linking Otezla to VOMITING. This represents approximately 1.7% of all 377,221 adverse event reports for this drug.

Patients taking Otezla who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING6,427 of 377,221 reports

VOMITING is a less commonly reported adverse event for Otezla, but still significant enough to appear in the safety profile.

Other Side Effects of Otezla

In addition to vomiting, the following adverse reactions have been reported for Otezla:

Frequently Asked Questions

Does Otezla cause VOMITING?

VOMITING has been reported as an adverse event in 6,427 FDA reports for Otezla. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with Otezla?

VOMITING accounts for approximately 1.7% of all adverse event reports for Otezla, making it a notable side effect.

What should I do if I experience VOMITING while taking Otezla?

If you experience vomiting while taking Otezla, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.